WeVote
Log In

Bill

Bill

SB 113

Medical Prescription Amendments

2026 General Session Introduced by Kirk Cullimore

SB 113 is a Utah prescription-related medical bill in early introduction stages; specific provisions remain undisclosed pending committee review.

Senate/ filed
#healthandhumanservices #business #controlledsubstances #controlledsubstancesdatabase #healthcare #healthcarefacilities #healthcareprofessionals #occupationalandprofessionallicensing #pharmaceuticals #pharmacies #pharmacists
0
WeVote Research Nonpartisan
Bill Summary · SB 113

Legislative bill overview

SB 113 is a Utah medical prescription bill introduced by Senator Kirk Cullimore that is currently in its early stages of the legislative process. The bill was formally introduced for first reading on January 20, 2026, and has not yet advanced to committee review or substantive debate.

Why is this important

Without access to the bill's specific text or summary, the exact policy implications cannot be determined. However, prescription-related legislation typically affects healthcare delivery, pharmaceutical access, costs, or regulatory procedures that impact patients, healthcare providers, and pharmacies across the state.

Potential points of contention

  • Lack of publicly available details: The bill's specific provisions, intent, and fiscal impact are not yet publicly documented, making it difficult for stakeholders to prepare testimony or responses.
  • Unknown stakeholder impact: Depending on the bill's content, it could affect various groups differently—including patients, physicians, pharmacists, insurance companies, or pharmaceutical manufacturers.
  • Early stage uncertainty: With only a first reading completed, the bill may undergo substantial revisions before advancing further in the legislative process.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.